Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Biotalys N.V. (BTLS.BR)
EUR3.00
-0.05 (-1.48%)
BE BRU Basic Materials Agricultural Inputs
Address
Buchtenstraat 11 9051
Gent, BE
Gent, BE
CEO
Carlo Boutton
Website
biotalys.com
IPO
2021-07-02
ISIN BE0974386188
Description
Biotalys N.V. is an agricultural technology firm dedicated to innovating and creating advanced biological solutions for safeguarding both food and cultivated crops. Its product pipeline prominently features biofungicides, bioinsecticides, and biobactericides. Founded in 2013, the company, previously known as Agrosavfe NV, is based in Gent, Belgium.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR3.00
-0.05 (-1.48%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
40.9K
Beta
1.40
Float Shares
13.15M
Free Float %
35.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.21% | -4.47% | +39.70% | -2.80% | -42.68% | -17.51% | -11.75% | -55.02% | -60.29% | -60.29% | -60.29% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
3.00
DCF (Unlevered)
0.66
-78.0%
DCF (Levered)
0.68
-77.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
67% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 1 | +1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
4.78
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Agricultural Inputs: +9.5%—
-
EPS growth Agricultural Inputs: +23.0%-5.0% Q4'25: -0.9% (vs Q4'24)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%—
-
EBIT margin Agricultural Inputs: +9.7%—
-
ROIC Agricultural Inputs: +7.4%-384.9% Q4'25: -379.6% (vs Q4'24)
-
Share dilution Agricultural Inputs: +0.0%+12.8% Q4'25: +9.2% (vs Q4'24)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×0.00× Q4'25: 0.00× (vs Q4'24)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 2 EPS Ana. |
Dec 2027 1 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 2.00M (-100.0%)
|
—
est: 2.95B (-100.0%)
|
—
est: 134.0K (-100.0%)
|
—
est: 3.00M (-100.0%)
|
—
est: 2.51M (-100.0%)
|
4.58M
4.58M – 4.58M
+82.7% YoY
|
5.73M
5.73M – 5.73M
+25.1% YoY
|
8.70M
8.70M – 8.70M
+51.8% YoY
|
| EBITDA |
-16.77M
|
-20.95M
|
-19.51M
|
-12.35M
|
-13.86M
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-17.58M
|
-22.53M
|
-20.89M
|
-13.49M
|
-15.65M
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-16.93M
|
-22.73M
|
-20.51M
est: -19.07M (-7.6%)
|
-13.19M
est: -13.87M (+5.0%)
|
-15.76M
est: -14.44M (-9.2%)
|
-12.44M
-13.76M – -11.12M
+13.8% YoY
|
-10.55M
-12.66M – -8.45M
+15.2% YoY
|
-10.31M
-10.50M – -10.12M
+2.3% YoY
|
| SGA |
6.19M
|
6.67M
|
6.89M
|
5.72M
|
5.62M
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-0.56
|
-0.74
|
-0.65
est: -0.51 (-27.8%)
|
-0.40
est: -0.37 (-8.1%)
|
-0.42
est: -0.38 (-9.7%)
|
-0.33
-0.37 – -0.30
+13.3% YoY
|
-0.28
-0.34 – -0.23
+14.5% YoY
|
-0.28
-0.28 – -0.27
+3.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Ownership data is not available for this company yet.
Executive team
Top executives
Shares Outstanding
37.57M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kevin R. Helash | Chief Executive Officer & Executive Director | 380.5K | male |
| Luc Van Fraeyenhoven | Chief Financial Officer | 101.5K | male |
| Carlo Boutton | Interim CEO & Chief Scientific Officer | — | — |
| Kamal El Mernissi | Chief Business Development Officer | — | male |
| Toon Musschoot | Head of Investor Relations & Communication | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BTLS.BR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
